Omics biotechnology
•Download as PPTX, PDF•
0 likes•740 views
This document discusses several omics technologies and bioengineering techniques including: 1) Different branches of omics technologies such as proteomics, pharmacogenomics, and synthetic biology. 2) Techniques for analyzing nucleic acids like nucleic acid isolation, PCR, and blotting. 3) Recombinant DNA techniques for manipulating DNA. 4) Methods for protein analysis including gel electrophoresis, ELISA, and flow cytometry. 5) Immunohistochemistry for detecting antigens in tissue sections.
Report
Share
Report
Share
Recommended
Synthetic Genome
Introduction to Synthetic Genome
SYNTHETIC GENOMICS Study of Invitro chemical synthesis of genetic material i.e., DNA in the form of oligonucleotides, genes, or genomes with Computational techniques for its design. SYNTHETIC GENOME Artificially synthesised genome (invitro)
Metabolomics- concepts and applications
Metabolomics is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. Collectively, these small molecules and their interactions within a biological system are known as the metabolome.
Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms.
Metabolomics
Metabolomics is the systematic study of small molecule metabolites in a biological system. It involves identifying and quantifying metabolites on a large scale to investigate the biochemical processes and phenotype of cells, tissues or organisms. Some key points are:
- Metabolomics studies the metabolome, which is the complete set of small molecule metabolites present under certain conditions.
- It provides insights into cellular processes by capturing the biochemical activity and state through metabolic profiling or fingerprinting.
- Metabolomics has applications in fields like biomarker discovery, personalized medicine, agriculture and food/environmental testing.
Comparative genomics
This document provides a summary of a seminar on comparative genomics techniques. It discusses three levels of genome research: structural genomics, functional genomics, and comparative genomics. Comparative genomics involves analyzing and comparing different genomes to study gene content, function, organization, and evolution. Techniques discussed include genome sequencing, mapping, and bioinformatics tools. The document also outlines what can be compared between genomes and how comparative genomics has provided insights into evolution and gene function.
A Brief Introduction to Metabolomics
Metabolites have various functions, including fuel, structure, signaling, stimulatory and inhibitory effects on enzymes, catalytic activity of their own (usually as a cofactor to an enzyme), defense, and interactions with other organisms (e.g. pigments, odorants, and pheromones).
Metabolome refers to the complete set of chemical compounds involved in an organism's metabolism (such as metabolic intermediates, hormones and other signaling molecules, and secondary metabolites)
Metabolomics is the scientific study of chemical processes involving metabolites. Metabolomics is a relatively new member to the ‘-omics’ family of systems biology technologies.
Applications of bioinformatics, main by kk sahu
Introduction
Goals of Bioinformatics
Bioinformatics & Human Genome
Project
What can we do using bioinformatics ?
Applications of bioinformatics in various fields
1) Medicine
2) Evolutionary studies
3) Agriculture
4) Microbiology
5) Biotechnology
Conclusion
References
Omics era
The document discusses various "omics" fields of study including genomics, proteomics, metabolomics, and others. It provides definitions and descriptions of each type of omics, focusing on the large sets of biological molecules they each study such as genomes, proteomes, metabolomes, etc. It explains that omics fields examine biological data on a large scale and provide insights into biological processes, functions, and interactions on a systems-wide level.
GENOMICS AND BIOINFORMATICS
Genomics is a discipline in genetics that applies recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble and analyze the function and structure of genomes
Recommended
Synthetic Genome
Introduction to Synthetic Genome
SYNTHETIC GENOMICS Study of Invitro chemical synthesis of genetic material i.e., DNA in the form of oligonucleotides, genes, or genomes with Computational techniques for its design. SYNTHETIC GENOME Artificially synthesised genome (invitro)
Metabolomics- concepts and applications
Metabolomics is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. Collectively, these small molecules and their interactions within a biological system are known as the metabolome.
Metabolomics is an analytical profiling technique for measuring and comparing large numbers of metabolites present in biological samples. Combining high-throughput analytical chemistry and multivariate data analysis, metabolomics offers a window on metabolic mechanisms.
Metabolomics
Metabolomics is the systematic study of small molecule metabolites in a biological system. It involves identifying and quantifying metabolites on a large scale to investigate the biochemical processes and phenotype of cells, tissues or organisms. Some key points are:
- Metabolomics studies the metabolome, which is the complete set of small molecule metabolites present under certain conditions.
- It provides insights into cellular processes by capturing the biochemical activity and state through metabolic profiling or fingerprinting.
- Metabolomics has applications in fields like biomarker discovery, personalized medicine, agriculture and food/environmental testing.
Comparative genomics
This document provides a summary of a seminar on comparative genomics techniques. It discusses three levels of genome research: structural genomics, functional genomics, and comparative genomics. Comparative genomics involves analyzing and comparing different genomes to study gene content, function, organization, and evolution. Techniques discussed include genome sequencing, mapping, and bioinformatics tools. The document also outlines what can be compared between genomes and how comparative genomics has provided insights into evolution and gene function.
A Brief Introduction to Metabolomics
Metabolites have various functions, including fuel, structure, signaling, stimulatory and inhibitory effects on enzymes, catalytic activity of their own (usually as a cofactor to an enzyme), defense, and interactions with other organisms (e.g. pigments, odorants, and pheromones).
Metabolome refers to the complete set of chemical compounds involved in an organism's metabolism (such as metabolic intermediates, hormones and other signaling molecules, and secondary metabolites)
Metabolomics is the scientific study of chemical processes involving metabolites. Metabolomics is a relatively new member to the ‘-omics’ family of systems biology technologies.
Applications of bioinformatics, main by kk sahu
Introduction
Goals of Bioinformatics
Bioinformatics & Human Genome
Project
What can we do using bioinformatics ?
Applications of bioinformatics in various fields
1) Medicine
2) Evolutionary studies
3) Agriculture
4) Microbiology
5) Biotechnology
Conclusion
References
Omics era
The document discusses various "omics" fields of study including genomics, proteomics, metabolomics, and others. It provides definitions and descriptions of each type of omics, focusing on the large sets of biological molecules they each study such as genomes, proteomes, metabolomes, etc. It explains that omics fields examine biological data on a large scale and provide insights into biological processes, functions, and interactions on a systems-wide level.
GENOMICS AND BIOINFORMATICS
Genomics is a discipline in genetics that applies recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble and analyze the function and structure of genomes
Medical Biotechnology (Recent Development)
The document summarizes recent developments in medical biotechnology, including the Human Genome Project and applications of genetic testing. It discusses how the Human Genome Project mapped the human genome for under its estimated $3 billion budget. The project has fueled the discovery of over 1,800 disease genes. There are now over 2,000 genetic tests that can assess genetic risks for diseases and help with diagnosis. Biotechnology in hospitals utilizes pharmacogenomics to study how genes affect medication responses and gene therapy which uses genes to treat or prevent diseases.
Structural proteomics
Structural proteomics
Veenstra, T. (2006). Chapter 9. Structural Proteomicsby NMR. In Proteomics for biological discovery. Hoboken, N.J.: Wiley-Liss.
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
This set of slides gives an overview regarding the various omics technologies available and how they can be used for improvement in clinical setting or research
transgenic crops and their regulatory system
This document summarizes the steps involved in developing transgenic crops and the regulatory approval system for biotech crops in India. It discusses how transgenic crops are created by introducing transgenes using techniques like Agrobacterium transformation. It also outlines the Indian regulatory system overseen by organizations like GEAC, RCGM and IBSC that aim to ensure the safety of GM crops. The system involves approvals for research, field trials and environmental release of transgenic crops. However, limitations of the current system are that it lacks adequate risk assessment standards and procedures and does not fully incorporate international biosafety protocols.
Metabolomics
Metabolomics is ever evolving and rapidly progressing field. It involves studying set of metabolites inside a cell or body.
Comparative genomics
Comparative genomics involves comparing genomes to discover similarities and differences. It can provide insights into evolutionary relationships, help predict gene function, and aid in drug discovery. The first step is often aligning genome sequences using tools like BLAST or MUMmer. Genomes can then be compared at various levels, such as overall nucleotide statistics, genome structure, and coding/non-coding regions. Comparing gene and protein content across genomes helps predict functions. Conserved genomic features across species also aid prediction. Insights into genome evolution come from studying molecular events like inversions and duplications. Comparative genomics has impacted phylogenetics and drug target identification.
Biomarkers omics 1
This document provides an introduction to omics technology. It defines omics as the comprehensive study of complex biological systems focusing on large sets of biological molecules. The main types of omics technologies discussed are genomics, transcriptomics, proteomics, and metabolomics. The history of omics is traced back to the 1970s with the first genome sequencing. Omics uses the suffix -omics to refer to fields of study like genomics and focuses on the objects of study called omes, such as the genome or proteome. Software tools and databases are also mentioned that support various omics analyses.
History of Genomics
The document provides a history of genomics, beginning with Mendel's work in 1866 establishing the gene concept and laws of genetics. Key developments include the discovery of DNA in 1871, the chromosomal theory of inheritance in 1902, and the discovery of linkage in 1910. The structure of DNA was elucidated in the 1950s, leading to the development of recombinant DNA technology in the 1970s and DNA sequencing techniques in the 1970s-80s. The first whole genome of an organism was sequenced in 1995. More recent developments include next generation sequencing starting in 2005 and the advent of CRISPR/Cas9 genome editing in 2012. The document concludes with discussing the potential use of CRISPR to target genes in the diamondb
Microarray Data Analysis
Microarray technology allows researchers to analyze gene expression levels on a genomic scale. DNA microarrays contain many genes arranged on a slide that can be used to detect differences in gene expression between samples. The microarray workflow involves sample preparation, hybridization of labeled cDNA to the array, image scanning, data normalization and statistical analysis to identify differentially expressed genes between conditions. Multiple testing is a challenge and statistical methods must account for false positives and negatives.
Metagenomics
Metagenomics is the study of genetic material recovered directly from environmental samples without culturing. This field enables research on uncultured organisms and microbial communities. There are three main metagenomic approaches: biochemical, whole genome shotgun sequencing, and 16s rRNA sequencing. Metagenomics is being applied to study human microbiomes, discover new genes and enzymes, monitor environmental impacts, and characterize uncultured microbes. Future directions include identifying more novel products from uncultured bacteria and improving culture methods and bioinformatics tools.
Metagenomics
This document discusses the field of metagenomics, which involves directly extracting and sequencing genetic material from environmental samples without culturing individual microbial species. It provides a brief history of metagenomics from early microbiologists in the 17th century to recent large-scale sequencing projects. Methods of metagenomic analysis like sequence-driven and function-driven approaches are described. Applications to studying uncultured symbiotic microbes, extreme environments, and the human gut microbiome are also summarized.
Impacts of genomics, proteomics, and metabolomics ppt
This document discusses the impacts of genomics, proteomics, and metabolomics technologies, known collectively as "omics" technologies, on medicinal plant research. It describes how each type of omics technology works - genomics analyzes genetic information, proteomics studies proteins, and metabolomics qualitatively and quantitatively analyzes low molecular weight metabolites. These technologies allow comprehensive analysis of biological systems and open new perspectives for ethnobotanical and medicinal plant research. The document outlines specific applications of omics technologies, such as botanical identification, characterization of active components, standardization of herbal extracts, and drug metabolism studies. It also notes some disadvantages like expense and labor intensiveness.
Genomics types
Genomics types
1. Functional genomics
2. Structural genomics
3. Comparative genomics
Tools used in Genomics studies
Genome of E.coli
100 minutes genome map of E.coli
Bioinformatics Applications in Biotechnology
This document discusses the role of bioinformatics in biotechnology applications. It summarizes that bioinformatics has become essential for analyzing the vast amounts of genomic data generated from sequencing projects. It provides examples of how bioinformatics tools can be applied to microbial genome analysis, molecular medicine, drug development, next generation sequencing, and more. The document also outlines two major fields of bioinformatics - developing computational tools and databases, and generating biological knowledge to understand living systems.
Techniques of cell cloning
Introduction
What is cloning?
Why we want to do cloning?
History
Technique of cell cloning
Dolly – the sheep
Species cloned
Why persue animal cloning research?
Conclusion
Introduction
What is cloning?
Why we want to do cloning?
History
Technique of cell cloning
Dolly – the sheep
Species cloned
Why persue animal cloning research?
Conclusion
Comparative genomics
Comparative genomics involves systematically comparing genome sequences from different organisms. It uses computer programs to identify homologous genomic regions and align sequences at the base-pair level. Comparing genomes at different phylogenetic distances can provide insights into gene structure/function, evolution, and characteristics unique to each organism. Key tools for comparative genomics include genome browsers, aligners, and databases that classify orthologous gene clusters conserved across species.
Types of genomics ppt
The document discusses several types of genomics: structural genomics aims to determine the 3D structure of every protein encoded in a genome. Functional genomics determines the biological functions of genes and their products. Mutational genomics characterizes mutation-associated genes and links genotypes to transcriptional states. Comparative genomics compares genomic features between species to study evolution and identify conserved and unique genes.
Transcriptome analysis
The document provides an overview of the history and techniques of transcriptome analysis. It discusses how RNA was separated from DNA with the formulation of the central dogma in 1958. Key developments include the discoveries of messenger RNA, transfer RNA, and ribosomal RNA in the 1960s. The document outlines techniques such as serial analysis of gene expression (SAGE) and RNA sequencing (RNA-seq) that allow comprehensive analysis of gene expression patterns. It provides details on the basic steps and advantages of SAGE and describes how next generation sequencing revolutionized transcriptome analysis through massive parallel sequencing.
Gene expression profiling
Gene expression and transcript profiling involves determining the pattern of genes expressed at the transcriptional level under specific circumstances by measuring the expression of thousands of genes simultaneously. This allows one to understand cellular function. Common techniques for profiling include DNA microarrays, RNA sequencing, and EST tags. DNA microarrays involve hybridizing cDNA or cRNA samples to probes on a chip to determine relative abundance of sequences. RNA sequencing uses next-generation sequencing to reveal presence and quantity of RNA in a sample.
Interactomeee
1) Interactomics is the study of interactions between genes or proteins, including genetic and physical interactions.
2) Complementation groups can identify mutations in the same or different genes involved in the same pathway through genetic crosses of mutant organisms.
3) Modifier screens uncover new genes involved in a biological pathway by identifying mutations that alter the phenotype of an original mutant. Mapping protein-protein interaction networks provides a framework for understanding biology as an integrated system.
Molecular and Cellular Biologist_Tanima Mallik
Tanima Mallik has extensive experience in molecular biology, microbiology, and biochemistry. She holds two Master's degrees and has worked on several research projects investigating topics like the mechanism of ATP synthase and inducing apoptosis in lung cancer cells. Her skills include techniques like single molecule studies, PCR, chromatography, and microscopy. She has taught at the university level and is proficient in planning and executing research projects.
APPLICATIONS of Biotechnology
Biotechnology is the use of living organisms to develop useful products. Modern biotechnology techniques include isolating DNA, inserting genes into vectors, and transforming host cells. Applications include producing Bt crops for pest resistance, producing vaccines and diagnosing diseases. New advances include artificial lymph nodes, non-invasive cancer detection from saliva, smart contact lenses to monitor eye pressure, and machines that can scan the liver non-invasively. Biotechnology continues to progress rapidly with applications in agriculture, medicine, and other fields.
More Related Content
What's hot
Medical Biotechnology (Recent Development)
The document summarizes recent developments in medical biotechnology, including the Human Genome Project and applications of genetic testing. It discusses how the Human Genome Project mapped the human genome for under its estimated $3 billion budget. The project has fueled the discovery of over 1,800 disease genes. There are now over 2,000 genetic tests that can assess genetic risks for diseases and help with diagnosis. Biotechnology in hospitals utilizes pharmacogenomics to study how genes affect medication responses and gene therapy which uses genes to treat or prevent diseases.
Structural proteomics
Structural proteomics
Veenstra, T. (2006). Chapter 9. Structural Proteomicsby NMR. In Proteomics for biological discovery. Hoboken, N.J.: Wiley-Liss.
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
This set of slides gives an overview regarding the various omics technologies available and how they can be used for improvement in clinical setting or research
transgenic crops and their regulatory system
This document summarizes the steps involved in developing transgenic crops and the regulatory approval system for biotech crops in India. It discusses how transgenic crops are created by introducing transgenes using techniques like Agrobacterium transformation. It also outlines the Indian regulatory system overseen by organizations like GEAC, RCGM and IBSC that aim to ensure the safety of GM crops. The system involves approvals for research, field trials and environmental release of transgenic crops. However, limitations of the current system are that it lacks adequate risk assessment standards and procedures and does not fully incorporate international biosafety protocols.
Metabolomics
Metabolomics is ever evolving and rapidly progressing field. It involves studying set of metabolites inside a cell or body.
Comparative genomics
Comparative genomics involves comparing genomes to discover similarities and differences. It can provide insights into evolutionary relationships, help predict gene function, and aid in drug discovery. The first step is often aligning genome sequences using tools like BLAST or MUMmer. Genomes can then be compared at various levels, such as overall nucleotide statistics, genome structure, and coding/non-coding regions. Comparing gene and protein content across genomes helps predict functions. Conserved genomic features across species also aid prediction. Insights into genome evolution come from studying molecular events like inversions and duplications. Comparative genomics has impacted phylogenetics and drug target identification.
Biomarkers omics 1
This document provides an introduction to omics technology. It defines omics as the comprehensive study of complex biological systems focusing on large sets of biological molecules. The main types of omics technologies discussed are genomics, transcriptomics, proteomics, and metabolomics. The history of omics is traced back to the 1970s with the first genome sequencing. Omics uses the suffix -omics to refer to fields of study like genomics and focuses on the objects of study called omes, such as the genome or proteome. Software tools and databases are also mentioned that support various omics analyses.
History of Genomics
The document provides a history of genomics, beginning with Mendel's work in 1866 establishing the gene concept and laws of genetics. Key developments include the discovery of DNA in 1871, the chromosomal theory of inheritance in 1902, and the discovery of linkage in 1910. The structure of DNA was elucidated in the 1950s, leading to the development of recombinant DNA technology in the 1970s and DNA sequencing techniques in the 1970s-80s. The first whole genome of an organism was sequenced in 1995. More recent developments include next generation sequencing starting in 2005 and the advent of CRISPR/Cas9 genome editing in 2012. The document concludes with discussing the potential use of CRISPR to target genes in the diamondb
Microarray Data Analysis
Microarray technology allows researchers to analyze gene expression levels on a genomic scale. DNA microarrays contain many genes arranged on a slide that can be used to detect differences in gene expression between samples. The microarray workflow involves sample preparation, hybridization of labeled cDNA to the array, image scanning, data normalization and statistical analysis to identify differentially expressed genes between conditions. Multiple testing is a challenge and statistical methods must account for false positives and negatives.
Metagenomics
Metagenomics is the study of genetic material recovered directly from environmental samples without culturing. This field enables research on uncultured organisms and microbial communities. There are three main metagenomic approaches: biochemical, whole genome shotgun sequencing, and 16s rRNA sequencing. Metagenomics is being applied to study human microbiomes, discover new genes and enzymes, monitor environmental impacts, and characterize uncultured microbes. Future directions include identifying more novel products from uncultured bacteria and improving culture methods and bioinformatics tools.
Metagenomics
This document discusses the field of metagenomics, which involves directly extracting and sequencing genetic material from environmental samples without culturing individual microbial species. It provides a brief history of metagenomics from early microbiologists in the 17th century to recent large-scale sequencing projects. Methods of metagenomic analysis like sequence-driven and function-driven approaches are described. Applications to studying uncultured symbiotic microbes, extreme environments, and the human gut microbiome are also summarized.
Impacts of genomics, proteomics, and metabolomics ppt
This document discusses the impacts of genomics, proteomics, and metabolomics technologies, known collectively as "omics" technologies, on medicinal plant research. It describes how each type of omics technology works - genomics analyzes genetic information, proteomics studies proteins, and metabolomics qualitatively and quantitatively analyzes low molecular weight metabolites. These technologies allow comprehensive analysis of biological systems and open new perspectives for ethnobotanical and medicinal plant research. The document outlines specific applications of omics technologies, such as botanical identification, characterization of active components, standardization of herbal extracts, and drug metabolism studies. It also notes some disadvantages like expense and labor intensiveness.
Genomics types
Genomics types
1. Functional genomics
2. Structural genomics
3. Comparative genomics
Tools used in Genomics studies
Genome of E.coli
100 minutes genome map of E.coli
Bioinformatics Applications in Biotechnology
This document discusses the role of bioinformatics in biotechnology applications. It summarizes that bioinformatics has become essential for analyzing the vast amounts of genomic data generated from sequencing projects. It provides examples of how bioinformatics tools can be applied to microbial genome analysis, molecular medicine, drug development, next generation sequencing, and more. The document also outlines two major fields of bioinformatics - developing computational tools and databases, and generating biological knowledge to understand living systems.
Techniques of cell cloning
Introduction
What is cloning?
Why we want to do cloning?
History
Technique of cell cloning
Dolly – the sheep
Species cloned
Why persue animal cloning research?
Conclusion
Introduction
What is cloning?
Why we want to do cloning?
History
Technique of cell cloning
Dolly – the sheep
Species cloned
Why persue animal cloning research?
Conclusion
Comparative genomics
Comparative genomics involves systematically comparing genome sequences from different organisms. It uses computer programs to identify homologous genomic regions and align sequences at the base-pair level. Comparing genomes at different phylogenetic distances can provide insights into gene structure/function, evolution, and characteristics unique to each organism. Key tools for comparative genomics include genome browsers, aligners, and databases that classify orthologous gene clusters conserved across species.
Types of genomics ppt
The document discusses several types of genomics: structural genomics aims to determine the 3D structure of every protein encoded in a genome. Functional genomics determines the biological functions of genes and their products. Mutational genomics characterizes mutation-associated genes and links genotypes to transcriptional states. Comparative genomics compares genomic features between species to study evolution and identify conserved and unique genes.
Transcriptome analysis
The document provides an overview of the history and techniques of transcriptome analysis. It discusses how RNA was separated from DNA with the formulation of the central dogma in 1958. Key developments include the discoveries of messenger RNA, transfer RNA, and ribosomal RNA in the 1960s. The document outlines techniques such as serial analysis of gene expression (SAGE) and RNA sequencing (RNA-seq) that allow comprehensive analysis of gene expression patterns. It provides details on the basic steps and advantages of SAGE and describes how next generation sequencing revolutionized transcriptome analysis through massive parallel sequencing.
Gene expression profiling
Gene expression and transcript profiling involves determining the pattern of genes expressed at the transcriptional level under specific circumstances by measuring the expression of thousands of genes simultaneously. This allows one to understand cellular function. Common techniques for profiling include DNA microarrays, RNA sequencing, and EST tags. DNA microarrays involve hybridizing cDNA or cRNA samples to probes on a chip to determine relative abundance of sequences. RNA sequencing uses next-generation sequencing to reveal presence and quantity of RNA in a sample.
Interactomeee
1) Interactomics is the study of interactions between genes or proteins, including genetic and physical interactions.
2) Complementation groups can identify mutations in the same or different genes involved in the same pathway through genetic crosses of mutant organisms.
3) Modifier screens uncover new genes involved in a biological pathway by identifying mutations that alter the phenotype of an original mutant. Mapping protein-protein interaction networks provides a framework for understanding biology as an integrated system.
What's hot (20)
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
Genomics, Transcriptomics, Proteomics, Metabolomics - Basic concepts for clin...
Impacts of genomics, proteomics, and metabolomics ppt
Impacts of genomics, proteomics, and metabolomics ppt
Similar to Omics biotechnology
Molecular and Cellular Biologist_Tanima Mallik
Tanima Mallik has extensive experience in molecular biology, microbiology, and biochemistry. She holds two Master's degrees and has worked on several research projects investigating topics like the mechanism of ATP synthase and inducing apoptosis in lung cancer cells. Her skills include techniques like single molecule studies, PCR, chromatography, and microscopy. She has taught at the university level and is proficient in planning and executing research projects.
APPLICATIONS of Biotechnology
Biotechnology is the use of living organisms to develop useful products. Modern biotechnology techniques include isolating DNA, inserting genes into vectors, and transforming host cells. Applications include producing Bt crops for pest resistance, producing vaccines and diagnosing diseases. New advances include artificial lymph nodes, non-invasive cancer detection from saliva, smart contact lenses to monitor eye pressure, and machines that can scan the liver non-invasively. Biotechnology continues to progress rapidly with applications in agriculture, medicine, and other fields.
PEGS Korea 2015 the essential protein engineering summit
PEGS is Cambridge Healthtech institute (CHI)’s flagship biologics meeting, and is widely considered the industry’s leading event on protein and antibody engineering. Its successful accolades include an annual attendance of over 1800 participants at the PEGS Summit in Boston; a record attendance of over 500 attendees at PEGS Europe this year; a successful launch of PEGS China in 2014, and now, the announcement of the first PEGS Korea to be launched in September 2015.
The 3-day Inaugural PEGS Korea will bring together an international faculty consisting of scientists, engineers and executives from all over the world to share their expertise and experiences in protein and antibody engineering, particularly in developing next-generation therapeutics including ADCs, bispecifics, and immunomodulating antibodies.
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. With two consecutive years of 40% growth in attendance, and another year of expanded program coverage, this year’s event will feature:
•500 attendees
•150 technical presentations
•70+ scientific posters
•40+ sponsors & exhibitors
•Dedicated networking opportunities
•Exclusive exhibit & poster hours
•Interactive roundtable, breakout & panel discussions
Cell Based Assays 2012
The document announces the Cell Based Assays Conference to be held on June 26-27, 2012 in London. The conference will feature keynote speakers who will provide updates on cell based assays and their importance in pharmaceutical research. Sessions over the two days will cover topics like high-content screening, 3D cell models, GPCR signaling pathways, and applications of cell based assays in drug discovery. The conference is aimed at researchers in fields related to screening, pharmacology, and assay development.
Cell based assays 2012
The document announces the Cell Based Assays 2012 conference to be held on June 26-27 in London. It will feature keynote speakers providing updates on cell based assays and their significance for pharmaceutical research. Sessions will discuss the latest developments and provide beneficial debates. The conference is aimed at researchers in fields related to screening, pre-clinical research, pharmacology, and assay development. It is sponsored by InSphero AG, Lonza, and TAP Biosystems.
nanobiotechnology, achievements and development prospects
Nanobiotechnology has significant applications in fields like medicine, imaging, and drug delivery. It has been used to develop tools for intelligent drug delivery, gene therapy, biosensors, diagnostics, and biomaterials. Some key achievements include using nanoparticles for more precise disease detection, developing techniques to detect genetic sequences, creating protein chips to study proteomics, and developing systems to sort rare cells. Nanobiotechnology also shows promise for targeted drug delivery, gene delivery without viruses, using liposomes to cross cell membranes, engineering surfaces at the nanoscale, and streamlining the drug development process. Its future applications could include more precise diagnosis and regenerative medicine through technologies like nanosensors and nanomedicine. Continued development may help improve
Analytical testing services
Analytical testing service provides deep analysis of samples through biological, chemical and physical methods or high-tech instruments to accurately and rapidly detect trace contamination in products like microbes, viruses, adventitious cells and reagents. The document discusses services for detecting host cell proteins, residual DNA, next generation sequencing, and transmission electron microscopy to identify contamination which can be a major problem in manufacturing biological and clinical products.
SUSMITHA (1)
Susmitha Krishna is a student pursuing her MSc in Biotechnology from Amrita School of Biotechnology. She has a BSc in Biotechnology and is interested in cell biology, signal transduction in cancer biology, and developing new drugs to treat cancer at an affordable cost. Her areas of research include cell biology, cancer biology, and using nanotechnology to target diseases. She has experience with various laboratory techniques and exposure to tools like BLAST, ImageJ, and computer-aided drug design.
iFood 2017 - Food for the future: quality, safety and sustainability
Report of conference on scientific outcome of
NTU’s Food Science and Technology initiative (iFOOD)
Research Grant
Applied Biosystems: Products, Technologies, Future Innovations, Impact on Gen...
Applied Biosystems: Products, Technologies, Future Innovations, Impact on Gen...The Lifesciences Magazine
Key Products and Technologies of Applied Biosystems: 1. DNA Sequencing Instruments 2. Real-Time PCR Systems 3. Next-Generation Sequencing (NGS) 4. Capillary Electrophoresis CV - Archana Waghnani
Archana Waghnani has over 3 years of experience as a senior laboratory technician specializing in histopathology and cytology. She has extensive experience in tissue processing, staining, immunohistochemistry, immunofluorescence, and special staining. She is highly skilled in techniques such as grossing, embedding, cutting, staining slides, and assisting in FNAC procedures. She also trained other technicians, maintained laboratory equipment and documentation, and participated in continuing education conferences. She received qualifications as a cytotechnician from the Indian Academy of Cytologists.
Ankit Sharma Seminar Report..pdf
This seminar report discusses biosensors used in agriculture. It provides an overview of different types of biosensors including electrochemical, potentiometric, amperometric, calorimetric and optical biosensors. It discusses the principle of signal transduction that biosensors use to convert biological reactions into electrical signals. The report also examines the role of biosensors in agriculture for detecting crop diseases and pathogens in plants. Some advantages of biosensors include high sensitivity, selectivity and rapid response times. Potential disadvantages include susceptibility to interference and limited lifespan.
Maha cv-linkedin-03 June,2015
Current CV .
My objective is to obtain a rewarding and challenging research scientist position where my background and experience will contribute to the success of a growing company or research center.
Currently, I am a Senior Associate Scientist at Amgen Inc. and certified Molecular Biologist with the American Society of Clinical Pathology MB (ASCP). I have more than 10 years of experience in the biotechnology/ pharmaceutical industry. I am highly proficient in various lab techniques, technologies, and automation. I demonstrated consistent success in the execution of assay development and method validation activities supporting clinical stage programs within GCP and GLP regulated environments. I possess extensive experience in optimization and validation of drug potency assays (ELISA and cell based assays), protein purification and characterization, and DNA/RNA extraction and quantitation. I am a subject matter expertise in the areas of human and rodent cell lines propagation and tissue dis-aggregation. I have proven operational capabilities in the establishment of standard operating procedures to ensure our laboratory meets regulatory and business requirements.
I am a self-motivated professional who works effectively as an individual contributor or within a team matrix. As a quick learner, I can efficiently deliver results, easily adapt to changing environment and provide fresh ideas. My strengths include statistical analysis/guidance, report writing, and communication.
Thank you in advance for your consideration. Please feel free to call me at (805-990-6258), or by e-mail at (mahawally46@gmail.com) if you have questions or would like a list of references.
Sincerely,
Maha Rizk
Maha cv-linkedin-06 june2015
Maha W. Rizk is a senior-level researcher with over 10 years of experience in biotechnology and pharmaceuticals. She has expertise in oncology, inflammation, and neurological biomarkers as well as experience in drug discovery, preclinical studies, and clinical trials. Her technical skills include developing and validating cell-based assays, protein analysis, DNA/RNA extraction, and data analysis software. She currently works as a senior associate scientist at Amgen performing assays for oncology, inflammation, and neuroscience drug candidates.
SMi Group's 3rd annual Immunogenicity 2016 conference
This document provides information about an upcoming conference on immunogenicity taking place June 13-14, 2016 in London. It lists the schedule, speakers, and topics to be covered over the two days. The conference will explore approaches to standardizing immunogenicity assays, unwanted immunogenicity, integrating immunogenicity risk data to predict clinical outcomes, and other topics related to assessing and reducing the immunogenicity of biotherapeutics. Registration discounts are available by March 31st or April 29th. The conference is aimed at accelerating the commercialization of next generation biotherapeutics by adopting advanced immunogenicity assessments.
P-176_Immunogenicity 2016
This document provides information about an upcoming conference on immunogenicity to be held June 13-14, 2016 in London. It includes an overview of the conference sessions and speakers. The sessions will cover topics such as approaches to standardizing drug level and anti-drug antibody assays, unwanted immunogenicity, integrating immunogenicity risk data, immunogenicity of biologics and biosimilars, and the role of aggregation in immunogenicity. There will also be two half-day post-conference workshops on June 15 on standardizing assays for biotherapeutics and unwanted immunogenicity from the bench to the bedside. The conference is aimed at accelerating development and approval of next generation biotherapeutics by adopting
Immunogenicity 2016
SMi’s 3rd annual conference
Immunogenicity
13th and 14th June 2016, Holiday In Kensington Forum, London, UK.
Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by 2022, now is the time engage with industry experts to addresses the real challenges with immunogenicity including assay assessment, the role of aggregation, the introduction of nanobodies and many more!
For further information or to register please visit the event website www.immuno.co.uk or contact Matthew Apps on +44 (0) 207 827 6093 or mapps@smi-online.co.uk
Kurtz biomanufacturing
The document discusses developing curriculum to support careers in biomanufacturing and the bioeconomy. It proposes hands-on workshops for teachers and students to learn biomanufacturing concepts and techniques. These include transforming bacteria, purifying proteins through various types of chromatography, and analyzing purified proteins through electrophoresis. The goal is to promote STEM education and careers in the growing biomanufacturing industry.
Biotechnology
The document provides an overview of the field of biotechnology, including its history, key areas and applications. It discusses topics like genetic engineering, recombinant DNA technology, transgenic plants and animals, DNA microarrays, bioinformatics, and careers in biotechnology. The future prospects of biotechnology in addressing global challenges like food security and healthcare are also highlighted.
Similar to Omics biotechnology (20)
PEGS Korea 2015 the essential protein engineering summit
PEGS Korea 2015 the essential protein engineering summit
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
PEGS Europe Protein & Antibody Engineering Summit 2014 Agenda
nanobiotechnology, achievements and development prospects
nanobiotechnology, achievements and development prospects
iFood 2017 - Food for the future: quality, safety and sustainability
iFood 2017 - Food for the future: quality, safety and sustainability
Applied Biosystems: Products, Technologies, Future Innovations, Impact on Gen...
Applied Biosystems: Products, Technologies, Future Innovations, Impact on Gen...
SMi Group's 3rd annual Immunogenicity 2016 conference
SMi Group's 3rd annual Immunogenicity 2016 conference
More from Romissaa ali Esmail/ faculty of dentistry/Al-Azhar university
blood–brain barrier and uses of blood components as diagnostic tools.pptx
blood–brain barrier and uses of blood components as diagnostic tools.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
. HIV-1-infected monocyte–macrophages traverse the BBB and enter the CNS throughout the course of HIV-1 disease. Once in the brain, both free virus and virus-infected cells are able to infect neighboring resident microglia and astrocytes and possibly other cell types.
HIV-1-infected cells in both the periphery and the CNS give rise to elevated levels of viral proteins, including gp120, Tat, and Nef, and of host inflammatory mediators such as cytokines and chemokines.
It has been shown that the viral proteins may act alone or in concert with host cytokines and chemokines, affecting the integrity of the BBB. The pathological end point of these interactions may facilitate a positive feedback loop resulting in increased penetration of HIV into the CNS
blood–brain barrier and uses of blood components as diagnostic tools .pdf
blood–brain barrier and uses of blood components as diagnostic tools .pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
. HIV-1-infected monocyte–macrophages traverse the BBB and enter the CNS throughout the course of HIV-1 disease. Once in the brain, both free virus and virus-infected cells are able to infect neighboring resident microglia and astrocytes and possibly other cell types.
HIV-1-infected cells in both the periphery and the CNS give rise to elevated levels of viral proteins, including gp120, Tat, and Nef, and of host inflammatory mediators such as cytokines and chemokines.
It has been shown that the viral proteins may act alone or in concert with host cytokines and chemokines, affecting the integrity of the BBB. The pathological end point of these interactions may facilitate a positive feedback loop resulting in increased penetration of HIV into the CNS
gingival hyperplasia :underlying Pathological mechanisms.pdf
gingival hyperplasia :underlying Pathological mechanisms.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Inflammatory gingival hyperplasia is an inflammatory restraint to local irritant correlating with the gingiva; the irritant could be microbial like plaque and calculus.
Clinically present as deep red or bluish, considerably friable and fine with smooth glossy surface and commonly bleed easily [1].
These conditions are presented with the epithelial to mesenchymal transition (EMT), where the basal lamina show disruptions and epithelial cells migrate into connective tissue and change their phenotypes to fibroblast-like cells [12].
cancer stem cell : challenge in cancer treatment.pdf
cancer stem cell : challenge in cancer treatment.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Many evidences that CSCs also play a central role in the pathogenesis and progression of carcinomas of the head and neck (HNSCC), including OSCC,have been found.
Early tissue culture studies showed that only a subpopulation of OSCC cells can form expanding tumor colonies, suggesting that human OSCC may contain some form of stem cells and it was subsequently shown that only a small subpopulation of the cells in OSCC corresponds to tumor-initiating cells.
These finding are in accordance with CSCs concept (17,34) that the tumor mass is a mixture of (a) CSCs dividing themselves to feed the tumor's growth, b) transient amplifying cells that divide themselves a few times before maturing into (c) differentiated tumor cells that do not contribute to tumor growth (4).
The isolation of CSCs from oral cancers has mainly been performed with the CD44 marker that was initially used to isolate breast cancer CSCs.
Cancer stem cell : Challenge in cancer treatment.pptx
Cancer stem cell : Challenge in cancer treatment.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Many evidences that CSCs also play a central role in the pathogenesis and progression of carcinomas of the head and neck (HNSCC), including OSCC,have been found.
Early tissue culture studies showed that only a subpopulation of OSCC cells can form expanding tumor colonies, suggesting that human OSCC may contain some form of stem cells and it was subsequently shown that only a small subpopulation of the cells in OSCC corresponds to tumor-initiating cells.
These finding are in accordance with CSCs concept (17,34) that the tumor mass is a mixture of (a) CSCs dividing themselves to feed the tumor's growth, b) transient amplifying cells that divide themselves a few times before maturing into (c) differentiated tumor cells that do not contribute to tumor growth (4).
The isolation of CSCs from oral cancers has mainly been performed with the CD44 marker that was initially used to isolate breast cancer CSCs.
Cleidocranial Dysplasia (Dysostosis).pdf
Cleidocranial Dysplasia (Dysostosis).pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Clinical Description
Cleidocranial dysplasia (CCD) spectrum disorder is a skeletal dysplasia representing a clinical continuum ranging from classic CCD (triad of delayed closure of the cranial sutures, hypoplastic or aplastic clavicles, and dental abnormalities), to mild CCD, to isolated dental anomalies without other skeletal features [Golan et al 2000]. Most individuals are diagnosed because they have classic features. CCD spectrum disorder affects most prominently those bones derived from intramembranous ossification, such as the cranium and the clavicles, although bones formed through endochondral ossification can also be affected. Cooper et al [2001] recorded the natural history of 90 probands and 56 first- and second-degree relatives; findings highlight the clinical variability of this condition within affected members of the same family who harbor the same pathogenic variant. Roberts et al [2013] reviewed their experience with more than 100 affected individuals in South Africa.
Classic CCD. The most prominent clinical findings in individuals with classic CCD are listed in Suggestive Findings and include: abnormally large, wide-open fontanelles at birth that may remain open throughout life; clavicular hypoplasia resulting in narrow, sloping shoulders that can be opposed at the midline; and abnormal dentition
Further medical problems identified in individuals with CCD spectrum disorder include short stature, skeletal/orthopedic findings, dental complications, ENT complications, endocrine findings, and mild developmental delay.
Molecular Pathogenesis
RUNX2 encodes runt-related transcription factor 2 (RUNX2), a transcription factor involved in osteoblast differentiation and skeletal morphogenesis. RUNX2 is essential for osteoblast differentiation during intramembranous ossification as well as chondrocyte maturation during endochondral ossification [Zheng et al 2005]. RUNX2 contains an N-terminal stretch of consecutive polyglutamine and polyalanine repeats known as the Q/A domain, a runt domain, and a C-terminal proline/serine/threonine-rich (PST) activation domain. The runt domain is a 128-amino-acid polypeptide motif originally described in the Drosophila runt gene that has the unique ability to independently mediate DNA binding and protein heterodimerization [Zhou et al 1999].
The majority of RUNX2 pathogenic variants in individuals with classic CCD affect the runt domain and most are predicted to abolish DNA binding [Lee et al 1997, Mundlos et al 1997, Otto et al 2002]. Pathogenic missense variants cluster at arginine 225 (p.Arg225) of RUNX2, a critical residue for RUNX2 function. In vitro studies have shown that pathogenic missense variants at p.Arg225 interfere with nuclear accumulation of RUNX2.
Hypomorphic RUNX2 alleles with partial loss of protein function, c.90dupC and c.598A>G, are associated with mild CCD, isolated dental anomalies, and significant intrafamilial variability.
Mechanism of disease causation. Loss of function
RUNX2-spCleidocranial Dysplasia (Dysostosis).pptx
Cleidocranial Dysplasia (Dysostosis).pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Cleidocranial dysplasia (CCD) spectrum disorder is a skeletal dysplasia representing a clinical continuum ranging from classic CCD (triad of delayed closure of the cranial sutures, hypoplastic or aplastic clavicles, and dental abnormalities), to mild CCD, to isolated dental anomalies without other skeletal features [Golan et al 2000]. Most individuals are diagnosed because they have classic features. CCD spectrum disorder affects most prominently those bones derived from intramembranous ossification, such as the cranium and the clavicles, although bones formed through endochondral ossification can also be affected. Cooper et al [2001] recorded the natural history of 90 probands and 56 first- and second-degree relatives; findings highlight the clinical variability of this condition within affected members of the same family who harbor the same pathogenic variant. Roberts et al [2013] reviewed their experience with more than 100 affected individuals in South Africa.Inflammatory cells: double-edged sword its role in repair and inflammation.pptx
Inflammatory cells: double-edged sword its role in repair and inflammation.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Wound healing is a highly dynamic process and involves complex interactions of extracellular matrix molecules, soluble mediators, various resident cells, and infiltrating leukocyte subtypes.
The immediate goal in repair is to achieve tissue integrity and homeostasis
pemphigus vulgaris: autoimmune disease.pptx
pemphigus vulgaris: autoimmune disease.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
PV is caused by autoantibodies that target cadherins, specifically desmogleins, though there may be some role for desmocollin; thus, this is a type 2 hypersensitivity reaction.[24][25] Acantholysis, or the loss of keratinocyte–keratinocyte adhesion, is interrupted by circulating IgG autoantibodies to intercellular adhesion molecules.[26][27] Acantholysis is seen as a result of the autoantibodies destroying the intracellular connections, leading to bullae that can easily rupture (known clinically as the Nikolsky sign).
A “super-compensation hypothesis” recently submitted by Sinha et al. proposes that additional factors may also play a role in PV.[28] Multiple mechanisms for antibody-induced acantholysis have been suggested, including the induction of signal transduction and the inhibition of adhesive molecule function through steric hindrance, which can trigger cell separation.[29] The pathogenesis of PV has been described in more detail by Hammers et al.[30]
In patients with PV, autoantibodies against desmoglein 1 (Dsg 1) and desmoglein 3 (Dsg 3) is the purported cause.[31] Desmogleins are transmembrane glycoproteins that are an integral part of desmosomes which, in part, are required for cell–cell adhesion via interaction with intermediate filaments. The most common targets of desmoglein for IgG antibodies are the extracellular cadherin domains, which can result in the loss of desmosome-adhesive properties. These signaling pathways trigger endocytosis, depletion, and direct inhibition of Dsg 3 interactions.[32] It is generally believed that the amino portion of the cadherin proteins is most implicated in the pathogenesis of acantholysis leading to PV.[33]
Many animal models have shown that enzymatic inactivation of Dsg 1 and gene deletion of Dsg 3 results in pathology similar to PV.[34][35] This phenomenon was observed to be dose-dependent and suggests that reducing the circulating levels of IgG against Dsg 1 and Dsg 3 can improve patient outcomes.[36] In patients with primarily cutaneous disease, Dsg 1 likely plays a role more superficially, whereas Dsg 3 is more likely to be found in deeper cutaneous structures and mucous membranes.[37][38] The implication is that Dsg 3 can compensate for the absence of Dsg 1 in mucosal structures (thus demonstrating PV in cutaneous lesions only). In contrast, Dsg 1 without Dsg 3 is insufficient to manage mucous membranes or cutaneous lesions alone, implying that Dsg 1 is in lower proportion in mucous membranes.
The binding of antibodies to desmogleins has been confirmed by epitope mapping and is presumed to disrupt desmoglein binding by affecting steric hindrance.[39] Another theory for the pathophysiology of PV is the desmoglein nonassembly depletion hypothesis. This theory suggests that autoantibodies not only bind desmoglein but that they also bind each other, leading to crosslinking and the inability of desmosomes to maintain cell–cell adhesion.[40][41] Pemphigus Vulgaris: Autoimmune disease.pdf
Pemphigus Vulgaris: Autoimmune disease.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
PV is caused by autoantibodies that target cadherins, specifically desmogleins, though there may be some role for desmocollin; thus, this is a type 2 hypersensitivity reaction.[24][25] Acantholysis, or the loss of keratinocyte–keratinocyte adhesion, is interrupted by circulating IgG autoantibodies to intercellular adhesion molecules.[26][27] Acantholysis is seen as a result of the autoantibodies destroying the intracellular connections, leading to bullae that can easily rupture (known clinically as the Nikolsky sign).
A “super-compensation hypothesis” recently submitted by Sinha et al. proposes that additional factors may also play a role in PV.[28] Multiple mechanisms for antibody-induced acantholysis have been suggested, including the induction of signal transduction and the inhibition of adhesive molecule function through steric hindrance, which can trigger cell separation.[29] The pathogenesis of PV has been described in more detail by Hammers et al.[30]
In patients with PV, autoantibodies against desmoglein 1 (Dsg 1) and desmoglein 3 (Dsg 3) is the purported cause.[31] Desmogleins are transmembrane glycoproteins that are an integral part of desmosomes which, in part, are required for cell–cell adhesion via interaction with intermediate filaments. The most common targets of desmoglein for IgG antibodies are the extracellular cadherin domains, which can result in the loss of desmosome-adhesive properties. These signaling pathways trigger endocytosis, depletion, and direct inhibition of Dsg 3 interactions.[32] It is generally believed that the amino portion of the cadherin proteins is most implicated in the pathogenesis of acantholysis leading to PV.[33]
Many animal models have shown that enzymatic inactivation of Dsg 1 and gene deletion of Dsg 3 results in pathology similar to PV.[34][35] This phenomenon was observed to be dose-dependent and suggests that reducing the circulating levels of IgG against Dsg 1 and Dsg 3 can improve patient outcomes.[36] In patients with primarily cutaneous disease, Dsg 1 likely plays a role more superficially, whereas Dsg 3 is more likely to be found in deeper cutaneous structures and mucous membranes.[37][38] The implication is that Dsg 3 can compensate for the absence of Dsg 1 in mucosal structures (thus demonstrating PV in cutaneous lesions only). In contrast, Dsg 1 without Dsg 3 is insufficient to manage mucous membranes or cutaneous lesions alone, implying that Dsg 1 is in lower proportion in mucous membranes.
The binding of antibodies to desmogleins has been confirmed by epitope mapping and is presumed to disrupt desmoglein binding by affecting steric hindrance.[39] Another theory for the pathophysiology of PV is the desmoglein nonassembly depletion hypothesis. This theory suggests that autoantibodies not only bind desmoglein but that they also bind each other, leading to crosslinking and the inability of desmosomes to maintain cell–cell adhesion.[40][41] platelets: its role in normal and diseases.pptx
platelets: its role in normal and diseases.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
The primary function of platelets is their role in hemostasis. Briefly, under normal physiological conditions, platelets will adhere to and begin to spread over the surface of subendothelial cells exposed by damage to the vascular endothelium.(1) Adhesion is dependent on the platelet membrane glycoprotein lb complex. The von Willebrand factor (vWF) is required for both adhesion and spreading.
platelets :its role in normal and diseases.pdf
platelets :its role in normal and diseases.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
The primary function of platelets is their role in hemostasis. Briefly, under normal physiological conditions, platelets will adhere to and begin to spread over the surface of subendothelial cells exposed by damage to the vascular endothelium.(1) Adhesion is dependent on the platelet membrane glycoprotein lb complex. The von Willebrand factor (vWF) is required for both adhesion and spreading.
immunity: Immunity by equilibrium and antitumor immunity .pdf
immunity: Immunity by equilibrium and antitumor immunity .pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Phagocytosis begins with adhesion of the phagocyte surface receptors to the pathogen, which then is internalized into vesicles called phagosomes.
Inside the phagocyte, the phagosome fuses to lysosomes, whose contents are released with consequent digestion and pathogen elimination.
Changes in the oxidase’s gene system components present in phagolysosome membrane lead to disability in respiratory burst and generation of reactive oxygen species (ROS).
Immunity:Immunity by equilibrium Anti-Tumor Immunity and.pptx
Immunity:Immunity by equilibrium Anti-Tumor Immunity and.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Phagocytosis begins with adhesion of the phagocyte surface receptors to the pathogen, which then is internalized into vesicles called phagosomes.
Inside the phagocyte, the phagosome fuses to lysosomes, whose contents are released with consequent digestion and pathogen elimination.
Changes in the oxidase’s gene system components present in phagolysosome membrane lead to disability in respiratory burst and generation of reactive oxygen species (ROS).
hemostasis :Mechanism and causes of its dysregulation.pdf
hemostasis :Mechanism and causes of its dysregulation.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Platelets have many functions, including phagocytosis of viruses, latex, immune complexes and iron; maintenance of vascular integrity
by filling gaps that form in the endothelium and by directly supporting endothelial cells; synthesis and release of vWF in humans and some animal species, and fibronectin;
participating in surface adhesion andactivation processess (Caen and Rosa, 1995; Clemetson, 1995; Nurden, 1995);
production and release of potent smooth muscle and endothelial cell proliferating factor( s); and retraction of clots, a process that stabilizes the initial hemostatic plug and activates clot lysis.
Hemostasis: Mechanism and causes of its dysregulation.pptx
Hemostasis: Mechanism and causes of its dysregulation.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Platelets have many functions, including phagocytosis of viruses, latex, immune complexes and iron; maintenance of vascular integrity
by filling gaps that form in the endothelium and by directly supporting endothelial cells; synthesis and release of vWF in humans and some animal species, and fibronectin;
participating in surface adhesion andactivation processess (Caen and Rosa, 1995; Clemetson, 1995; Nurden, 1995);
production and release of potent smooth muscle and endothelial cell proliferating factor( s); and retraction of clots, a process that stabilizes the initial hemostatic plug and activates clot lysis.
tooth regeneration : Between Reality and Imagination.pdf
tooth regeneration : Between Reality and Imagination.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Tooth development proceeds with reciprocal inductive interactions between stomadeum ectoderm and underlying ectomesenchymal cells in a strictly controlled temporal and spatial order.
Well studied at the molecular biologic level, over 300 genes and 100 growth and differentiation factors are implicated in the control of cellular differentiation and crosstalk in dental development that result in structures containing combination of mineralized tissues (enamel, dentine, cementum), soft connective tissues (dental pulp, periodontal ligament), blood vessels, nerves and lymphatics.
tooth regeneration: Between Reality and Imagination.pptx
tooth regeneration: Between Reality and Imagination.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Tooth development proceeds with reciprocal inductive interactions between stomadeum ectoderm and underlying ectomesenchymal cells in a strictly controlled temporal and spatial order.
Well studied at the molecular biologic level, over 300 genes and 100 growth and differentiation factors are implicated in the control of cellular differentiation and crosstalk in dental development that result in structures containing combination of mineralized tissues (enamel, dentine, cementum), soft connective tissues (dental pulp, periodontal ligament), blood vessels, nerves and lymphaticsPolymerase chain Reaction: Concepts and Uses.pptx
Polymerase chain Reaction: Concepts and Uses.pptxRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Diagnostic polymerase chain reaction (PCR) is an extremely powerful, rapid method for diagnosis of microbial infections and genetic diseases, as well as for detecting microorganisms in environmental and food samples.
However, the usefulness of diagnostic PCR is limited, in part, by the presence of inhibitory substances in complex biological samples, which reduce or even block the amplification capacity of PCR in comparison with pure solutions of nucleic acids .
In general, diagnostic PCR may be divided into four steps: (1) sampling, (2) sample preparation, (3) nucleic acid amplification, and (4) detection of PCR products
polymerase chain reaction (PCR): Concepts and Indications.pdf
polymerase chain reaction (PCR): Concepts and Indications.pdfRomissaa ali Esmail/ faculty of dentistry/Al-Azhar university
Diagnostic polymerase chain reaction (PCR) is an extremely powerful, rapid method for diagnosis of microbial infections and genetic diseases, as well as for detecting microorganisms in environmental and food samples.
However, the usefulness of diagnostic PCR is limited, in part, by the presence of inhibitory substances in complex biological samples, which reduce or even block the amplification capacity of PCR in comparison with pure solutions of nucleic acids .
In general, diagnostic PCR may be divided into four steps: (1) sampling, (2) sample preparation, (3) nucleic acid amplification, and (4) detection of PCR products
More from Romissaa ali Esmail/ faculty of dentistry/Al-Azhar university (20)
blood–brain barrier and uses of blood components as diagnostic tools.pptx
blood–brain barrier and uses of blood components as diagnostic tools.pptx
blood–brain barrier and uses of blood components as diagnostic tools .pdf
blood–brain barrier and uses of blood components as diagnostic tools .pdf
gingival hyperplasia :underlying Pathological mechanisms.pdf
gingival hyperplasia :underlying Pathological mechanisms.pdf
cancer stem cell : challenge in cancer treatment.pdf
cancer stem cell : challenge in cancer treatment.pdf
Cancer stem cell : Challenge in cancer treatment.pptx
Cancer stem cell : Challenge in cancer treatment.pptx
Inflammatory cells: double-edged sword its role in repair and inflammation.pptx
Inflammatory cells: double-edged sword its role in repair and inflammation.pptx
immunity: Immunity by equilibrium and antitumor immunity .pdf
immunity: Immunity by equilibrium and antitumor immunity .pdf
Immunity:Immunity by equilibrium Anti-Tumor Immunity and.pptx
Immunity:Immunity by equilibrium Anti-Tumor Immunity and.pptx
hemostasis :Mechanism and causes of its dysregulation.pdf
hemostasis :Mechanism and causes of its dysregulation.pdf
Hemostasis: Mechanism and causes of its dysregulation.pptx
Hemostasis: Mechanism and causes of its dysregulation.pptx
tooth regeneration : Between Reality and Imagination.pdf
tooth regeneration : Between Reality and Imagination.pdf
tooth regeneration: Between Reality and Imagination.pptx
tooth regeneration: Between Reality and Imagination.pptx
polymerase chain reaction (PCR): Concepts and Indications.pdf
polymerase chain reaction (PCR): Concepts and Indications.pdf
Recently uploaded
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeProf. Marcus Renato de Carvalho
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
STIs may cause PID. For the both disease, herbal medicine Fuyan Pill can be a solution.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Best Ayurvedic medicine for Gas and Indigestion
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Top 10 Best Ayurvedic Kidney Stone Syrups in India
we have mentioned the best 10 ayurvedic Kidney Stone Syrups. You can check all these products and choose the best one for yourself.
ABDOMINAL TRAUMA in pediatrics part one.
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
The Best Ayurvedic Antacid Tablets in India
Treat the symptoms of indigestion, heartburn and stomach reflux with the 10 Best Ayurvedic Antacid Tablets in India.
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations Recently uploaded (20)
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
Omics biotechnology
- 2. Part:1 By Romissaa Aly Assistant lecturer of Oral Medicine, Periodontology, Diagnosis and Dental Radiology (Al-Azhar Univerisity) OMICS TECHNOLOGIES AND BIO-ENGINEERING
- 3. Different branches of OMICS TECHNOLOGIES
- 9. Microorganisms used for recombinant Protein Production
- 14. Application of Pharmaco genomics
- 20. Nutri-genomics
- 24. Continue
- 26. Continue
- 29. Continue
- 34. Continue
- 36. Steps of DNA fingerprinting
- 38. Lab-on-a-Chip Technology and Its Applications
- 43. 3D Printing Technologies and Their Applications in Biomedical Science
- 56. PROTOCOLS AND PIPELINES FOR METAGENOMIC ANALYSIS
- 59. NUCLEIC ACID ISOLATION TECHNIQUES
- 61. Continue
- 66. PCR
- 75. Continue
- 76. Continue
- 77. Continue
- 79. TECHNIQUES FOR PROTEIN ANALYSIS
- 80. Continue
- 87. ELISA
- 93. Engineering Monoclonal Antibodies: Production and Applications
- 100. Flow cytometery
- 103. Immunohistochemistry (IHC) is a method for detecting antigens or haptens in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. The antibody-antigen binding can be visualized in different manners.
- 105. continue
- 107. references